Sayers: Amgen Tour of California could be "wild west"

With a US base in Northern California, the BMC Racing Team and its director Mike Sayers of Sacramento have a distinct advantage of having intimate first-hand knowledge of the Amgen Tour of California's opening stages. Giving his analysis of this year's course, Sayers said the results on the key stage to Mt. Baldy at the end of the race will be affected by the surprisingly difficult opening four days in addition to the time trial and Big Bear stage which precedes it.

Thank you for reading 5 articles in the past 30 days*

Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read any 5 articles for free in each 30-day period, this automatically resets

After your trial you will be billed £4.99 $7.99 €5.99 per month, cancel anytime. Or sign up for one year for just £49 $79 €59

Join now for unlimited access

Try your first month for just £1 / $1 / €1

Laura Weislo
Managing Editor

Laura Weislo has been with Cyclingnews since 2006 after making a switch from a career in science. As Managing Editor, she coordinates coverage for North American events and global news. As former elite-level road racer who dabbled in cyclo-cross and track, Laura has a passion for all three disciplines. When not working she likes to go camping and explore lesser traveled roads, paths and gravel tracks. Laura specialises in covering doping, anti-doping, UCI governance and performing data analysis.